Display Title ENDO April 2017 Weight 0 Tags ENDO April 2017 Content REPLENISH trial: 17β-Estradiol and Progesterone Combined in a Single Capsule (TX-001HR) Significantly Improved Moderate-to-Severe Vasomotor Symptoms in Postmenopausal Women 1.1 MB REPLENISH Trial: Endometrial Safety with a 17β-Estradiol and Progesterone Combination (TX-001HR) in Postmenopausal Women with Vasomotor Symptoms 331 KB Categories Publications
